New Delhi: Stem cell research is a very fast growing field. The scientific community has witnessed major development in the field from autologous to allogeneic mesenchymal to embryonic and now induced pluripotent stem cells. ICMR has been regularly receiving claims on possible therapeutic solutions for varied disease conditions using stem cell.
Taking into consideration this situation and to understand position of India in global scenario, the Director General, ICMR invites ‘Letter of Claim’ on therapeutic use of stem cells from all entities including government, private, clinicians, hospitals, Industries etc in the country. The document should be restricted to 2 pages describing the claims with details of the team involved and with approval from Head of the organization. A separate set of documents should be submitted for each condition/disease.
The ‘Letter of Claim’ should reach Dr Geeta Jotwani, Scientist E, Division of Basic Medical Sciences, ICMR Headquarters latest by 31st December 2016. This is first and the last opportunity to all the concerned claimants for submission of their data. No such claims will be entertained after the deadline, mentioned the notification.